Ventricular tachycardia

583,497views

Ventricular tachycardia

IM EOR

IM EOR

Angina pectoris
Premature atrial contraction
Premature ventricular contraction
Supraventricular arrhythmias: Pathology review
Ventricular tachycardia
Ventricular fibrillation
Atrial flutter
Atrial fibrillation
Wolff-Parkinson-White syndrome
Atrioventricular nodal reentrant tachycardia (AVNRT)
Long QT syndrome and Torsade de pointes
Stable angina
Unstable angina
Prinzmetal angina
Class I antiarrhythmics: Sodium channel blockers
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy
Heart failure
Diabetes mellitus
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Insulins
Diabetes insipidus
Hypercalcemia
Hypocalcemia
Hypernatremia
Hyponatremia
Hyperparathyroidism
Hypoparathyroidism
Hypercholesterolemia: Clinical
Lipid-lowering medications: Statins
Coronary artery disease: Clinical
Endocarditis
Class II antiarrhythmics: Beta blockers
Peptic ulcer
Acute pancreatitis
Chronic pancreatitis
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Gastritis
Thiazide and thiazide-like diuretics
ACE inhibitors, ARBs and direct renin inhibitors
ECG cardiac infarction and ischemia
Abnormal heart sounds
Pulmonary valve disease
Tricuspid valve disease
cGMP mediated smooth muscle vasodilators
Sarcoidosis
Mycobacterium tuberculosis (Tuberculosis)
Pneumonia
Myocardial infarction
Adrenergic antagonists: Beta blockers
Hyperthyroidism
Hypothyroidism
Thyroid storm
Hypertension: Clinical
Class IV antiarrhythmics: Calcium channel blockers and others
Calcium channel blockers
Asthma
Emphysema
Pericarditis and pericardial effusion
Cardiac tamponade
Antiplatelet medications
Primary adrenal insufficiency
Pheochromocytoma
Cushing syndrome
Ischemic stroke
Bell palsy
Multiple sclerosis
Guillain-Barre syndrome
Bundle branch block
Migraine
Tension headache
Cluster headache
Syncope: Clinical
Transient ischemic attack
Non-steroidal anti-inflammatory drugs
Fibromyalgia
Gout
Systemic lupus erythematosus
Iron deficiency anemia
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Pulmonary hypertension
Pneumothorax
Lung cancer
Pulmonary embolism
Pseudomonas aeruginosa
Clostridium botulinum (Botulism)
Vitamin B12 deficiency
Influenza virus
Sickle cell disease (NORD)
Treponema pallidum (Syphilis)
Clostridium tetani (Tetanus)
Borrelia burgdorferi (Lyme disease)
Protein C deficiency
Folate (Vitamin B9) deficiency
Factor V Leiden
Protein S deficiency
Antithrombin III deficiency
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Paget disease of bone
Antiphospholipid syndrome
Rheumatoid arthritis
Ulcerative colitis
Candida
Cryptococcus neoformans
Positive and negative predictive value
Cirrhosis
Thyroid cancer
Shock
Neisseria gonorrhoeae
Pituitary adenoma
Seizures and epilepsy
Bordetella pertussis (Whooping cough)
Prostatitis
Meningitis
Vibrio cholerae (Cholera)
Testicular torsion
Epididymitis
Polycystic kidney disease
Polymyalgia rheumatica
Polymyositis
Hemorrhoid
Portal hypertension
Varicocele
Varicella zoster virus
Irritable bowel syndrome
Cytomegalovirus
Acid reducing medications
Concussion and traumatic brain injury
Hepatocellular carcinoma
Renal artery stenosis
Rheumatic heart disease
Cor pulmonale
Gastroesophageal reflux disease (GERD)
Sjogren syndrome
Huntington disease
Scleroderma
Acute cholecystitis
Viral hepatitis
Appendicitis
Diverticulosis and diverticulitis
Kidney stones
Acute pyelonephritis
Chronic pyelonephritis
Lower urinary tract infection
Glaucoma
Ascending cholangitis
Non-urothelial bladder cancers
Hydronephrosis
Celiac disease
Benign prostatic hyperplasia
Prerenal azotemia
Renal azotemia
Postrenal azotemia
Chronic kidney disease
Poststreptococcal glomerulonephritis
Membranous nephropathy
Membranoproliferative glomerulonephritis
IgA nephropathy (NORD)
Acute tubular necrosis
Acute kidney injury: Clinical
Chronic kidney disease: Clinical
Alport syndrome
Parkinson disease
Encephalitis
Delirium
Dementia with Lewy bodies
Vascular dementia
Frontotemporal dementia
Alzheimer disease
Adult brain tumors
Acid-base map and compensatory mechanisms
Erectile dysfunction
Acromegaly
Esophageal web
Esophageal disorders: Clinical
Colorectal cancer
Rapidly progressive glomerulonephritis
Goodpasture syndrome
Esophageal cancer
Gastric cancer
Esophagitis: Clinical
HIV (AIDS)
Anemia of chronic disease
Beta-thalassemia
Anemia of chronic disease
Alpha-thalassemia
Multiple myeloma
Shigella
Toxoplasma gondii (Toxoplasmosis)
Histoplasmosis
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Pneumonia: Clinical

Transcript

Watch video only

Content Reviewers

Ventricular refers to the bottom chambers of the heart, the right and left ventricles, as opposed to the top chambers, the right and left atria. Tachycardia refers to a fast heart rate. Typically, a tachycardic, or fast, heart rate is considered anything above 100 beats per minute, or bpm. However, ventricular tachycardia is different than a fast heart rate from exercising, which is called sinus tachycardia.

Normally, the electrical signals that generate each heartbeat start in the right atrium at the sinus node, which is also known as the sinoatrial node, or the SA node. If the rate goes over 100 bpm and originates in the SA node, it’s considered sinus tachycardia, which is totally normal.

However, heartbeats can become abnormal if the electrical signals don’t start in the SA node, but start in the ventricles instead. Premature Ventricular Contractions, or PVCs, are single beats originating from the lower chambers. Any time there are more than three beats like this in a row, then it’s defined as ventricular tachycardia. Ventricular tachycardia, sometimes called V-tach, or VT, can cause the heart rate to rise above 100 beats per minute, which can be extremely dangerous and lead to sudden cardiac death.

Hold on, how can that happen? It’s not like while we exercise we’re risking sudden cardiac death, right? Well, even though we say tachycardia is anything above 100 beats per minute, most patients with ventricular tachycardia experience heart rates as high as 250 beats per minute. 250 beats per minute mean that the heart is beating over four times per second. When the chambers are pumping that fast, they don’t have enough time to even fill with blood, so the heart is furiously pumping out only tablespoons of blood to your body, and most importantly, to your brain, which is just not enough. If this happens, a person can have symptoms from not having enough perfusion to their tissues, such as chest pain, fainting, dizziness, or shortness of breath. It can even cause sudden death.

Now, there are essentially two ways an electrical signal can start in a ventricle: either the signal is focal, or it’s reentrant. Focal V-tach happens when a specific area of the ventricle has abnormal automaticity. The automaticity rate is the frequency at which a cell sends out a signal, so for the pacemaker cells in the SA node, the rate is between about 60 and 100 signals per minute, resulting in 60 to 100 beats per minute. Let’s just say 60 beats per minute, so one beat every second. Some specialized pacemaker cells in the ventricles also have this ability; they’re just usually a lot slower, making about 30 beats per minute, or one beat every two seconds. So, in most cases, the SA node fires signals off a lot faster, which sends electrical waves throughout the atria and ventricles. This doesn’t give the ventricular pacemaker cells a chance to ever have just two seconds of peace, which is what they need before they fire at a rate of 30 bpm.

For example, imagine all the other pacemaker cells stopped suddenly. After two seconds, the ventricular cells would initiate a signal, right? Now, if a certain area of ventricular tissue gets stressed or irritated in some way, the ventricular pacemaker cells might start firing at higher rates. They essentially flip roles with the SA node, firing so fast that the pacemaker cells in the SA node don’t get a chance to fire; at this point, the heartbeat is being driven by the ventricles. This stress might be triggered by: certain medications; illicit drugs, such as methamphetamine or cocaine; electrolyte imbalances; and ischemia to the ventricular muscle.

However, it’s more common for V-tach to be reentrant, as opposed to focal. So, let’s take a closer look at the cardiomyocytes, or heart muscles cells, instead of the pacemaker cells. These can be stressed in a similar way, which might change a couple of their properties, including how fast they relay, or conduct the signal to the next cell, and how long their refractory period is. Now, the refractory period is the period right after conducting a signal when the cells can’t conduct another signal.

All right, to help explain this, let’s say the myocardial tissue on side A conducts really fast, so the electrical signal zips through; however, it takes a long time to be able to conduct again. In other words, it has a long refractory period. The other side, or side B, is the exact opposite; it has slow conduction and a short refractory period. Now, this isn’t entirely unusual, since the heart can naturally have tissue with different properties. But let’s say that this tissue becomes damaged, and some of these cells actually die, like with a heart attack. Well, now you’ll get some scar tissue, which really can’t conduct the signal as well. Sometimes, this can create a sort of split pathway, where it goes around the scar and meets back up on the other side.

Under these conditions, it’s possible that a reentrant circuit develops. Okay, if one signal comes through, that’s fine. On side A, the wave makes it around first and goes on to the rest of the ventricle, and contracts the ventricle. It also starts up the other path, and sort of runs into the other, slower wave, which is called a unidirectional block.

Key Takeaways

Ventricular tachycardia is a type of tachycardia, or a rapid heartbeat that arises from improper electrical activity of the heart presenting as a rapid heart rhythm that starts in the ventricles. There are two main types of ventricular tachycardia: monomorphic, and polymorphic ventricular tachycardias.

In monomorphic ventricular tachycardia, all the beats look the same because the impulse is either being generated from increased automaticity of a single point in either the left or the right ventricle, or due to a reentry circuit within the ventricle. Polymorphic ventricular tachycardia, on the other hand, is most commonly caused by abnormalities of ventricular muscle repolarization. Ventricular tachycardia is a potentially life-threatening arrhythmia because it can cause low blood pressure and may lead to ventricular fibrillation, asystole, and sudden death. Ventricular tachycardia ranges between 100 and 250 bpm.